NKTR-358 bolsters T-cells’ ability to respond to immune inflammatory disorders such as lupus, according to a preclinical-trial study. Nektar Therapeutics said…
Articles by Alice Melão
French pharmaceutical firm Neovacs has completed enrollment for a Phase 2b clinical trial (IFN-K-002) to evaluate the efficacy and safety of IFNα-Kinoid to…
An injected formulation of Benlysta (belimumab) is a safe and effective lupus treatment, according to a Phase 3 clinical trial…
Voclosporin, an investigational therapy developed by Canada’s Aurinia Pharmaceuticals, is more effective at treating lupus nephritis (LN) than other calcineurin inhibitors, according…
Servier and ILTOO Pharma have joined forces with an exclusive license agreement for the development and commercialization of…
Patients with systemic lupus erythematosus (SLE) are twice as likely to suffer a potentially fatal pulmonary embolism (PE) as people without…
The presence of antiphospholipid antibodies (aPL) in circulation may aid identify patients at risk for pulmonary hypertension (PH) and…
A large Chinese cohort study has shown that anti-pentraxin 3 (PTX3) auto-antibodies were less prevalent in lupus nephritis patients with…
Benlysta reduced systemic lupus erythematosus (SLE) activity and improved patient outcomes, but smokers and those with significant organ damage failed to…
Evaluating heart function using an electrocardiogram (ECG) can be a useful noninvasive tool for early detection of patients with systemic…